Quality infrastructure sits behind the catalogue: an independent laboratory of more than 12,000 square metres, over 400 precision instruments and a technical team of 300-plus, operating to ISO 9001:2015, ISO 17025 and cGMP with CNAS accreditation and ILAC-MRA recognition. Beyond small molecules, MCE stocks recombinant proteins, oligonucleotides including siRNAs, antisense sequences, aptamers, CpG ODNs and mRNA, lipids and LNP components, antibody-drug conjugate linkers and payloads, peptide-drug and radionuclide-drug conjugates, isotope-labelled compounds, fluorescent dyes, reference standards and GMP-grade small molecules. The screening collections run to 74 signaling pathway libraries and 45 disease-focused libraries, plus fragment, DNA-encoded, AI-enabled, natural product and Traditional Chinese Medicine sets. Laboratory services cover kinase, ion channel, GPCR and nuclear receptor screening, surface plasmon resonance, high-content screening, affinity mass spectrometry, molecular docking and custom peptide or oligonucleotide synthesis.

